Bioenergetic bypass using cell-permeable succinate, but not methylene blue, attenuates metformin-induced lactate production
Sarah Piel(Düsseldorf University Hospital), Magnus J. Hansson(Medicon Village), Eleonor Åsander Frostner(Lund University), Eskil Elmér(Medicon Village), Fredrik Sjövall(Skåne University Hospital), Imen Chamkha(Lund University), Johannes K. Ehinger(Lund University)
Cited by 26
Related Papers
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
|Intensive Care Medicine|2020|1.1k
Update on Immunologic Therapy With Anti–CTLA-4 Antibodies in Melanoma: Identification of Clinical and Biological Response Patterns, Immune-Related Adverse Events, and Their Management
|Seminars in Oncology|2010|170
Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock
|JAMA|2024|154
Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency
|Nature Communications|2016|153
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study
|Intensive Care Medicine|2020|117